DavidL.KellyMD

PubMed

• Genistein treatment duration effects biomarkers of cell motility in human prostate.
  Zhang, H.,Gordon, R.,Li, W.,Yang, X.,Pattanayak, A.,Fowler, G.,Zhang, L.,Catalona, W. J.,Ding, Y.,Xu, L.,Huang, X.,Jovanovic, B.,Kelly, D. L.,Jiang, H.,Bergan, R.> ;PLoS ONE. 2019 Mar 28
• A simple fluorescent assay for the discovery of protein-protein interaction inhibitors.
  Al-Mugotir, M.,Kolar, C.,Vance, K.,Kelly, D. L.,Natarajan, A.,Borgstahl, GEO.> ;Anal. Biochem.. 2019 Feb 02
• A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cells.
  Das, B.,Neilsen, B. K.,Fisher, K. W.,Gehring, D.,Hu, Y.,Volle, D. J.,Kim, H. S.,McCall, J. L.,Kelly, D. L.,MacMillan, J. B.,White, M. A.,Lewis, R. E.> ;Sci Rep. 2018 Mar 02
• 27 citations
  AMPK Promotes Aberrant PGC1β Expression To Support Human Colon Tumor Cell Survival
  Kurt W. Fisher, Binita Das, Hyun Seok Kim, Beth K. Clymer, Drew Gehring, Deandra R. Smith, Diane L. Costanzo-Garvey, Mario R. Fernandez, Michael G. Brattain, David Lee...> ;Molecular and Cellular Biology. 2015 Nov 15
• A Kinase Inhibitor Screen Reveals PKC-dependent Endocytic Recycling of ErbB2 in Breast Cancer Cells.
  Bailey, T. A.,Luan, H.,Tom, E.,Bielecki, T. A.,Mohapatra, B.,Ahmad, G.,George, M.,Kelly, D. L.,Natarajan, A.,Raja, S. M.,Band, V.,Band, H.> ;J. Biol. Chem.. 2014 Sep 17
• Transcriptional activation of the type II transforming growth factor-beta receptor gene upon differentiation of embryonal carcinoma cells.
  Kelly D, Kim SJ, Rizzino A> ;J. Biol. Chem.. 1998-08-14
• The effect of dexamethasone in vivo on blood and peritoneal neutrophils (PMN) in rabbits with peritonitis.
  Sheng FC, Freischlag JA, Backstrom B, Kelly D, Busuttil RW> ;J. Surg. Res.. 1987-09-01
• Comparison of blood and peritoneal neutrophil activity in rabbits with and without peritonitis.
  Freischlag J, Backstrom B, Kelly D, Keehn G, Busuttil RW> ;J. Surg. Res.. 1986-02-01
• MUC1 regulates cyclin D1 gene expression through p120 catenin and β-catenin.
  Liu, X.,Caffrey, T. C.,Steele, M. M.,Mohr, A.,Singh, P. K.,Radhakrishnan, P.,Kelly, D. L.,Wen, Y.,Hollingsworth, M. A.> ;Oncogenesis. 2014 Jul 01
• RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses.
  Panda, D., Das, A., Dinh, P. X., Subramaniam, S., Nayak, D., Barrows, N. J., Pearson, J. L., Thompson, J., Kelly, D. L., Ladunga, I., Pattnaik, A. K.> ;Proc Natl Acad Sci U S A. 2011 Nov 22
• 2,3-Substituted quinoxalin-6-amine analogs as antiproliferatives: a structure-activity relationship study.
  Chen, Q., Bryant, V. C., Lopez, H., Kelly, D. L., Luo, X., Natarajan, A.> ;Bioorg Med Chem Lett. 2011 Apr 1
• Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion.
  Barbolina, M. V., Adley, B. P., Kelly, D. L., Shepard, J., Fought, A. J., Scholtens, D., Penzes, P., Shea, L. D., Stack, M. S.> ;Int J Cancer. 2009 Aug 15
• Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant.
  Sharma, A. K., Zhang, L., Li, S., Kelly, D. L., Alakhov, V. Y., Batrakova, E. V., Kabanov, A. V.> ;J Control Release. 2008 Nov 12
• RNA interference-mediated inhibition of hepatocyte nuclear factor 1alpha identifies target genes.
  Evans, J. R., Kelly, D. L., Morris, K. J., Arvide, E. M., Harris, A.> ;Biochim Biophys Acta. 2008 May
• Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma.
  Barbolina, M. V., Adley, B. P., Kelly, D. L., Fought, A. J., Scholtens, D. M., Shea, L. D., Stack, M. S.> ;Lab Invest. 2008 Jun
• The methodology used to measure differential gene expression affects the outcome.
  Ding, Y., Xu, L., Jovanovic, B. D., Helenowski, I. B., Kelly, D. L., Catalona, W. J., Yang, X. J., Pins, M., Bergan, R. C.> ;J Biomol Tech. 2007 Dec
• Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1.
  Golkar, L., Ding, X. Z., Ujiki, M. B., Salabat, M. R., Kelly, D. L., Scholtens, D., Fought, A. J., Bentrem, D. J., Talamonti, M. S., Bell, R. H., Adrian, T. E.> ;J Surg Res. 2007 Apr
• Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85.
  Batrakova, E. V., Kelly, D. L., Li, S., Li, Y., Yang, Z., Xiao, L., Alakhova, D. Y., Sherman, S., Alakhov, V. Y., Kabanov, A. V.> ;Mol Pharm. 2006 Mar 01
• Identification and in silico characterization of a novel gene: TPA induced trans-membrane protein.
  Chan, C. Y., Salabat, M. R., Ding, X. Z., Kelly, D. L., Talamonti, M. S., Bell, R. H., Adrian, T. E.> ;Biochem Biophys Res Commun. 2005 Apr 8
• Polymer genomics: shifting the gene and drug delivery paradigms.
  Kabanov, A. V., Batrakova, E. V., Sriadibhatla, S., Yang, Z., Kelly, D. L., Alakov, V. Y.> ;J Control Release. 2005 Jan 3
• Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line.
  Kohlgraf, K. G., Gawron, A. J., Higashi, M., Meza, J. L., Burdick, M. D., Kitajima, S., Kelly, D. L., Caffrey, T. C., Hollingsworth, M. A.> ;Cancer Res. 2003 Aug 15
• Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells.
  Karan, D., Kelly, D. L., Rizzino, A., Lin, M. F., Batra, S. K.> ;Carcinogenesis. 2002 Jun
• Join now to see all